References
- Nisce L, D'Angio G D. Radiotherapy of Hodgkin's disease. Hodgkin's Disease, M J Lacher. Wiley, New York 1976; 145–177
- Lacher M J. Primary treatment of Hodgkin's disease with sequential radiation therapy and multidrug chemotherapy without initial laparotomy-splenectomy. Progress in Clinical Cancer, I Ariel. Grune & Stratton, New York 1982; 283–297
- Andrieu J M, Ochoa-Molina M E. Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease. Cancer 1983; 52: 435–438
- Lacher M J, Toner K. Evaluation of impact on ovarian function of combined radiation therapy and chemotherapy using thiotepa, vinblastine, vincristine, prednisone, procarbazine (RT/TVPP) in Hodgkin's disease. Proc Am Soc Clin One 1984; C946: 242, abst
- Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
- Wiernik P H, Gustafson J, Schimpff S C, et al. Combined modality treatment of Hodgkin's disease confined to lymph nodes. Am J Med 1979; 67: 183–193
- Rosenberg S A, Kaplan H S, Hoppe R T. An overview of the rationale and results of Stanford randomized trials of the treatment of Hodgkin's disease: 1967–1980. Adjuvant Therapy of Cancer III, S E Salmon, S E Jones. Grune & Stratton, New York 1981
- Nissen N I, Nordentoft A M. Radiotherapy versus combined modality treatment of Stage I and II Hodgkin's disease. Cancer Treat Rep 1982; 66: 799–803
- Horning S J, Hoppe R T, Kaplan H S, et al. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981; 304: 1377–1382
- Waxman J HX, Terry Y A, Wrigley P FM, et al. Gonadal function in Hodgkin's disease: Long-term follow-up of chemotherapy. Br Med J 1982; 285: 1612–1613
- Chapman R M, Sutcliffe S B, Malpas J S. Cytotoxic-induced ovarian failure in women with Hodgkin's disease: Hormone function. JAMA 1979; 242: 1877–1881
- Sutcliffe S B. Cytotoxic chemotherapy and gonadal function in patients with Hodgkin's disease. JAMA 1979; 242: 1898–1899
- Schilsky R L, Sherins R J, Hubbard S M, et al. Long-term follow-up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med 1981; 71: 552–556
- Ray G R, Trueblood H W, Enright L P, et al. Oophoropexy: A means of preserving menstrual function following pelvic megavoltage radiation for Hodgkin's disease. Radiology 1970; 96: 175–180
- Thomas P RM, Winstanly D, Beckham M J, et al. Reproductive and endocrine function in patients with Hodgkin's disease: Effects of oophoropexy and irradiation. Br J Cancer 1976; 33: 226–231
- Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in “normal” couples. N Engl J Med 1978; 299: 111–115
- Rucknagel D L. Reproductive potential after treatment for Hodgkin's disease. Letter to the editor. N Engl J Med 1981; 305: 890–891